QuickSwitch™ Quant HLA-A*02:01-BV421 and Peptides Bundle 1
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
| Target | SARS-CoV-2 ORF1ab (3122-3130), SARS-CoV-2 ORF1ab (3183-3191), SARS-CoV-2 ORF1ab (3710-3718), SARS-CoV-2 ORF1ab (3732-3740), SARS-CoV-2 ORF1ab (6419-6427), SARS-CoV-2 ORF1ab (6749-6758), SARS-CoV-2 ORF1ab (6851-6859), SARS-CoV-2 ORF3a protein (139-147) |
|---|---|
| Product Type | Peptide, Tetramer |
| Application | FCM |
| Class | Class I |
| Species Reactivity | Human |
| Peptide Sequence | FLAHIQWMV, FLLNKEMYL, LLLDDFVEII, LLYDANYFL, SMWALIISV, TLMNVLTLV, YLDAYNMMI, YLNTLTLAV |
| Research Area | Immunology, Immune Monitoring |
| Protocols | FCM |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
Related Products
Related Content
